| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:39 UTC |
|---|
| HMDB ID | HMDB0014538 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Beclometasone dipropionate |
|---|
| Description | Beclometasone dipropionate is a prodrug of the free form, beclometasone. An anti-inflammatory, synthetic glucocorticoid, it is used topically as an anti-inflammatory agent and in aerosol form for the treatment of asthma. Beclometasone dipropionate is also being investigated for oral treatment in mild-to-moderate Crohn's disease of ileal or ileal-right colonic localisation and for 'topical' use mild-to-moderate graft versus host disease. |
|---|
| Structure | [H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (11beta,16beta)-9-Chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione | ChEBI | | 9-Chloro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate | ChEBI | | 9-Chloro-16beta-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate | ChEBI | | Aerobec | ChEBI | | Aldecin | ChEBI | | Anceron | ChEBI | | Andion | ChEBI | | Beclacin | ChEBI | | Becloforte | ChEBI | | Beclomet | ChEBI | | Beclometasone 17,21-dipropionate | ChEBI | | Beclorhinol | ChEBI | | Becloval | ChEBI | | Beclovent | ChEBI | | Becodisks | ChEBI | | Beconase | ChEBI | | Beconasol | ChEBI | | Becotide | ChEBI | | Clenil-a | ChEBI | | Entyderma | ChEBI | | Inalone | ChEBI | | Korbutone | ChEBI | | Propaderm | ChEBI | | Rino-clenil | ChEBI | | Sanasthmax | ChEBI | | Sanasthmyl | ChEBI | | Vancenase | ChEBI | | Vanceril | ChEBI | | Viarex | ChEBI | | Viarox | ChEBI | | Qnasl | Kegg | | (11b,16b)-9-Chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione | Generator | | (11Β,16β)-9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione | Generator | | 9-Chloro-11b-hydroxy-16b-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate | Generator | | 9-Chloro-11b-hydroxy-16b-methylpregna-1,4-diene-3,20-dione 17,21-dipropionic acid | Generator | | 9-Chloro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionic acid | Generator | | 9-Chloro-11β-hydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate | Generator | | 9-Chloro-11β-hydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-dipropionic acid | Generator | | 9-Chloro-16b-methyl-11b,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate | Generator | | 9-Chloro-16b-methyl-11b,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionic acid | Generator | | 9-Chloro-16beta-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionic acid | Generator | | 9-Chloro-16β-methyl-11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate | Generator | | 9-Chloro-16β-methyl-11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionic acid | Generator | | Beclometasone 17,21-dipropionic acid | Generator | | Beclometasone dipropionic acid | Generator | | Beclomethasone dipropionate | HMDB | | 3m Brand OF beclomethasone dipropionate | HMDB | | Asche brand OF beclomethasone dipropionate | HMDB | | Asmabec clickhaler | HMDB | | Beclocort | HMDB | | Medeva brand OF beclomethasone dipropionate | HMDB | | Orion brand OF beclomethasone dipropionate | HMDB | | AeroBec forte | HMDB | | Allen and hanburys brand OF beclomethasone dipropionate | HMDB | | Apotex brand OF beclomethasone dipropionate | HMDB | | Ascocortonyl | HMDB | | Beclamet | HMDB | | Beclo azu | HMDB | | Becloturmant | HMDB | | Filair | HMDB | | Norton brand OF beclomethasone dipropionate | HMDB | | Prolair | HMDB | | Schering-plough brand OF beclomethasone dipropionate | HMDB | | Aldo brand OF beclomethasone dipropionate | HMDB | | Azupharma brand OF beclomethasone dipropionate | HMDB | | Beclo asma | HMDB | | Beclometasone | HMDB | | Beclomethasone | HMDB | | Beconase aq | HMDB | | Dipropionate, beclomethasone | HMDB | | Filair forte | HMDB | | Fujisawa brand OF beclomethasone dipropionate | HMDB | | Glaxo wellcome brand OF beclomethasone dipropionate | HMDB | | GlaxoSmithKline brand 1 OF beclomethasone dipropionate | HMDB | | GlaxoSmithKline brand 3 OF beclomethasone dipropionate | HMDB | | Junik | HMDB | | Nasobec aqueous | HMDB | | Respocort | HMDB | | Shire brand OF beclomethasone dipropionate | HMDB | | Becodisk | HMDB | | Qvar | HMDB | | Schering brand 1 OF beclomethasone dipropionate | HMDB | | United drug brand OF beclomethasone dipropionate | HMDB | | a And H brand OF beclomethasone dipropionate | HMDB | | Apo-beclomethasone | HMDB | | Beclazone | HMDB | | Beclazone easy breathe | HMDB | | Bemedrex easyhaler | HMDB | | Bronchocort | HMDB | | Celltech brand OF beclomethasone dipropionate | HMDB | | Ecobec | HMDB | | GlaxoSmithKline brand 2 OF beclomethasone dipropionate | HMDB | | Ivax brand OF beclomethasone dipropionate | HMDB | | Schering brand 2 OF beclomethasone dipropionate | HMDB | | Ventolair | HMDB | | Viarin | HMDB | | Beclomethasone dipropionic acid | HMDB | | Beclometasone dipropionate | ChEBI |
|
|---|
| Chemical Formula | C28H37ClO7 |
|---|
| Average Molecular Weight | 521.042 |
|---|
| Monoisotopic Molecular Weight | 520.222781245 |
|---|
| IUPAC Name | 2-[(1R,2S,10S,11S,13S,14R,15S,17S)-1-chloro-17-hydroxy-2,13,15-trimethyl-5-oxo-14-(propanoyloxy)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-14-yl]-2-oxoethyl propanoate |
|---|
| Traditional Name | beconase |
|---|
| CAS Registry Number | 5534-09-8 |
|---|
| SMILES | [H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C |
|---|
| InChI Identifier | InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1 |
|---|
| InChI Key | KUVIULQEHSCUHY-XYWKZLDCSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Pregnane steroids |
|---|
| Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Progestogin-skeleton
- Steroid ester
- 20-oxosteroid
- 3-oxo-delta-1,4-steroid
- 3-oxosteroid
- 11-hydroxysteroid
- 11-beta-hydroxysteroid
- Oxosteroid
- 9-halo-steroid
- Halo-steroid
- Hydroxysteroid
- Delta-1,4-steroid
- Alpha-acyloxy ketone
- Dicarboxylic acid or derivatives
- Cyclic alcohol
- Carboxylic acid ester
- Chlorohydrin
- Cyclic ketone
- Secondary alcohol
- Halohydrin
- Ketone
- Carboxylic acid derivative
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Organochloride
- Organohalogen compound
- Alkyl chloride
- Alkyl halide
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 117 - 120 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0021 g/L | Not Available | | LogP | 1.3 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.57 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 20.6262 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.09 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3425.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 395.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 249.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 190.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 229.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 945.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 839.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 95.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1686.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 664.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1992.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 596.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 490.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 235.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 504.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Beclometasone dipropionate,1TMS,isomer #1 | CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O[Si](C)(C)C)C[C@@]21C | 3692.7 | Semi standard non polar | 33892256 | | Beclometasone dipropionate,1TMS,isomer #2 | CCC(=O)OC=C(O[Si](C)(C)C)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C | 3746.4 | Semi standard non polar | 33892256 | | Beclometasone dipropionate,2TMS,isomer #1 | CCC(=O)OC=C(O[Si](C)(C)C)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O[Si](C)(C)C)C[C@@]21C | 3666.3 | Semi standard non polar | 33892256 | | Beclometasone dipropionate,2TMS,isomer #1 | CCC(=O)OC=C(O[Si](C)(C)C)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O[Si](C)(C)C)C[C@@]21C | 3585.1 | Standard non polar | 33892256 | | Beclometasone dipropionate,2TMS,isomer #1 | CCC(=O)OC=C(O[Si](C)(C)C)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O[Si](C)(C)C)C[C@@]21C | 4395.2 | Standard polar | 33892256 | | Beclometasone dipropionate,1TBDMS,isomer #1 | CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3931.5 | Semi standard non polar | 33892256 | | Beclometasone dipropionate,1TBDMS,isomer #2 | CCC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C | 3973.6 | Semi standard non polar | 33892256 | | Beclometasone dipropionate,2TBDMS,isomer #1 | CCC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 4121.6 | Semi standard non polar | 33892256 | | Beclometasone dipropionate,2TBDMS,isomer #1 | CCC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3983.9 | Standard non polar | 33892256 | | Beclometasone dipropionate,2TBDMS,isomer #1 | CCC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 4534.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Beclometasone dipropionate GC-MS (Non-derivatized) - 70eV, Positive | splash10-00pi-7931200000-ebf9cfbf75bf09c67c7a | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Beclometasone dipropionate GC-MS (1 TMS) - 70eV, Positive | splash10-0bvi-9427050000-eb3614d4b3688b88c0c8 | 2017-10-06 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Beclometasone dipropionate LC-ESI-qTof , Positive-QTOF | splash10-000f-0930000000-081eac0a05abab8fc5fa | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Beclometasone dipropionate LC-ESI-qTof , Positive-QTOF | splash10-000f-0930000000-081eac0a05abab8fc5fa | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Beclometasone dipropionate LC-ESI-qTof , Positive-QTOF | splash10-0a4i-3920000000-d6e2b1ac89621299e6bb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Beclometasone dipropionate , positive-QTOF | splash10-0536-0000390000-d1146b326a2bf27937e3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Beclometasone dipropionate , positive-QTOF | splash10-0udi-0489240000-9581961e5dddfb7a403f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Beclometasone dipropionate , positive-QTOF | splash10-0h71-3892000000-454fb634c4339a1ebfe0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 10V, Positive-QTOF | splash10-0kmj-4001960000-2444d4d01b60622dc9da | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 20V, Positive-QTOF | splash10-0a4i-9016710000-03228f1ad114124f50a8 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 40V, Positive-QTOF | splash10-0ab9-7259300000-8a403afc0efa6ee4f110 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 10V, Negative-QTOF | splash10-0600-9000440000-d5250fc13ae4ff60aa89 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 20V, Negative-QTOF | splash10-05fr-9001300000-fb71d87f62527dae4806 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 40V, Negative-QTOF | splash10-05fr-9002000000-182d2c80d6e083b565f0 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 10V, Positive-QTOF | splash10-00di-0009730000-81e60ed81d61c6314c37 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 20V, Positive-QTOF | splash10-01xx-0009200000-d06a88f89fcfe1e37e3f | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 40V, Positive-QTOF | splash10-000i-9627500000-178854364472c3c4dd81 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 10V, Negative-QTOF | splash10-00di-9006200000-345f47155712cbf26442 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 20V, Negative-QTOF | splash10-05fr-9003000000-fa1ac5e3b880b5467f13 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Beclometasone dipropionate 40V, Negative-QTOF | splash10-0ab9-9000000000-89a0f1c5a6da8df63c3c | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Willey RF, Milne LJ, Crompton GK, Grant IW: Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest. 1976 Jan;70(1):32-8. [PubMed:1259918 ]
- Salzman GA, Pyszczynski DR: Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol. 1988 Feb;81(2):424-8. [PubMed:3339197 ]
- Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S: Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol. 2003 Jun;90(6):646-51. [PubMed:12839324 ]
- Castilla C, Perez-Simon JA, Sanchez-Guijo FM, Diez-Campelo M, Ocio E, Perez-Persona E, Lopez-Villar O, Vazquez L, Caballero D, San Miguel JF: Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD). Biol Blood Marrow Transplant. 2006 Sep;12(9):936-41. [PubMed:16920559 ]
- Hockenbery DM, Cruickshank S, Rodell TC, Gooley T, Schuening F, Rowley S, David D, Brunvand M, Berryman B, Abhyankar S, Bouvier M, McDonald GB: A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood. 2007 May 15;109(10):4557-63. Epub 2007 Jan 23. [PubMed:17244684 ]
- Astegiano M, Pagano N, Sapone N, Simondi D, Bertolusso L, Bresso F, Demarchi B, Pellicano R, Bonardi R, Marconi S, Rizzetto M: Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study. Biomed Pharmacother. 2007 Jul;61(6):370-6. Epub 2007 Mar 12. [PubMed:17399941 ]
- McDonald GB: Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation. Expert Opin Investig Drugs. 2007 Oct;16(10):1709-24. [PubMed:17922633 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- (). FDA label.. .
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
|---|